Novo Nordisk inks $2.2B deal to develop weight-loss pill to rival Lilly’s orforglipron
Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last month.
Health Care & Life Sciences
-
Once-hyped IU Health People Mover fades into oblivion
IU Health’s People Mover is unusual—or it certainly was at the time it was conceived—because of its use of public right of way.
Read More -
IU LAB announces accelerator partnerships with Gener8tor, Plug and Play
In addition, IU LAB announced that its accelerator programs will now be called IU Health Incubator at IU LAB, thanks to a $4.5 million, three-year sponsorship deal with IU Health.
Read More -
Q&A with the head of Lilly manufacturing, who meticulously tracks gains in work, life
“People come together, operators, with their supervisors at 6 a.m. every morning, and they talk about what issues they have and how they propose to solve it. Those get escalated through all levels of management.”
Read More -
Q&A: OrthoIndy’s John Ryan talks about staying independent in a consolidating health care industry
The economics are daunting: Rising costs and flat reimbursements mean private groups must work harder to stay independent.
Read More
Articles
Zimmer Biomet ‘cementless’ partial knee implant makes Indiana debut
The Zimmer Biomet Oxford Cementless Partial Knee System received FDA approval in November, although the implant has been used in more than 300,000 procedures outside the U.S.
UPDATE: Roche Diagnostics to invest up to $550M in Indianapolis, adding hundreds of local jobs
The Swiss pharmaceutical and diagnostics giant said the move will establish the Indianapolis-based Roche Diagnostics site as a hub for manufacturing of its continuous glucose monitoring system.
‘Innovation at every stage’: Lilly to invest up to $250M in broadened alliance with Purdue University
The extended partnership holds the potential to be the largest industry-academic agreement of its kind in the United States, Purdue President Mung Chiang said.
Lilly shuffles roles amid growth in U.S. investment, diabetes and obesity treatments
The company has announced more than $50 billion in new U.S. manufacturing investments since 2020.
Lilly chief scientist talks drugmaker’s new $4.5B campus, recruiting and innovation
Chief Scientific Officer Dr. Daniel Skovronsky talked with the IBJ about his hopes for the Lilly Medicine Foundry, which the Indianapolis-based drugmaker broke ground on this week.
Lilly breaks ground on $4.5B foundry campus in Lebanon’s LEAP District
Officials from the Indianapolis-based drugmaker said the Lilly Medicine Foundry will help streamline the process of discovering new medicines and getting them to patients.
Elanco ramps up debt repayment, sells future royalties of flea and tick medicine for human use
Greenfield-based Elanco Health on Monday announced the $295 million cash sale of future U.S. royalty and milestone rights for the human use of a medication typically used for dogs and cats.
Preserving young patient’s hair prompts IU surgeons’ invention
The desire to preserve a girl’s flowing hair during brain surgery led to the development of a comb-like device that could help cranial surgery patients avoid having their heads shaved.
Pricing legislation shows health reform complexities
Indiana lawmakers discovered this legislative session that performing major financial surgery on multibillion-dollar nonprofit hospital systems is a motley and entangled task.
Roche Diagnostics hopes new self-collection HPV test will expand screening for cervical cancer risk
The test, one of the first of its kind, is designed to reach patients who may forgo traditional screening because of lack of access, past trauma or embarrassment.
Community Health Network MD Anderson Cancer Center expands into Carmel
The Carmel center, which opened Monday, has 17 infusion rooms, eight rooms for clinical visits, a procedure room and a pharmacy.
Lilly sues Indianapolis clinic for selling split doses of popular weight-loss drugs
The drugmaker accuses Premier Weight Loss of risking patients’ health by selling altered, unsterile versions of its blockbuster drugs Mounjaro and Zepbound.
Skyrocketing cost of weight-loss drugs has state Medicaid programs looking for solution
At least 14 states already cover the cost of GLP-1 medications for obesity treatment for patients on Medicaid. Indiana is not one of them.
Carmel-based health tech firm to delist from Nasdaq
Syra Health Corp. plans to offer stock on the over-the-counter market after the company failed to meet Nasdaq Stock Market’s price requirements for its shares.
Lilly adds online education, care services for Alzheimer’s to LillyDirect platform
The company said its goal is to reduce wait times for patients seeking access to specialists, creating more opportunities for early diagnosis and intervention.
Johnson & Johnson plans $55B in United States investments
Aside from building four new plants, Johnson & Johnson said that it will expand several existing sites.
Big Ten schools team up when it comes to cancer research
Indianapolis has been awash in Big Ten logos amid the conference’s basketball tournaments. But Indy is home to another sort of Big Ten gathering—one focused on improving cancer research.
Sen. Young: US must prevail in AI race against China
Speaking at IBJ’s Technology Power Breakfast on Monday, U.S. Sen. Todd Young of Indiana also discussed the challenge of striking a balance between encouraging innovation in artificial intelligence and developing necessary guardrails.
Zepbound raises profile of Lilly’s direct-to-consumer sales initiative
Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to connect directly with consumers on the platform since.